* Celcuity Inc CELC.OQ reported a quarterly adjusted loss
of 62
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -66
cents. The mean expectation of seven analysts for the quarter
was for a loss of 68 cents per share. Wall Street expected
results to range from -76 cents to -60 cents per share.
* Reported revenue was zero; analysts expected zero.
* Celcuity Inc's reported EPS for the quarter was a loss
of 62
cents.
* The company reported a quarterly loss of $23.72 million.
* Celcuity Inc shares had risen by 2.7% this quarter and
gained 15.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Celcuity Inc is
$27.00
This summary was machine generated from LSEG data August 15 at
04:55 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.68 -0.62 Beat
Mar. 31 2024 -0.71 -0.64 Beat
Dec. 31 2023 -0.73 -0.65 Beat
Sep. 30 2023 -0.68 -0.83 Missed